Searched for
GEFITINIB
- AstraZeneca stock rallies as patent plea for cancer drug rejectedShares of AstraZeneca were witnessing selling pressure on reports that’s its patent plea on anti-cancer drug Gefitinib were rejected.
Patents appeal board rejects AstraZeneca's plea on cancer drugPatents appeal board has dismissed AstraZeneca's petition challenging an earlier ruling that refused patent protection for a cancer-fightin...- India's first patent tech auction in Ahmedabad this weekA herbal drink that tastes like beer, a bio-insecticide product that attracts and kills mosquitoes using bird feather constitute a few samp...
- Load More